FRIDAY, Dec. 12, 2025 More than half of people with a rare life-threatening bleeding condition received lasting relief from an experimental antibody treatment,
Experimental Drug, Lanalumab, Provides Lasting Relief For Bleeding Condition
Latest from Blog
You lost weight on a GLP-1, but are you really healthy?
Weight-loss drugs like Ozempic are getting stronger, but could greater weight loss lead to worse malnutrition? Post Views: 2
Beet Supplements Market Forecast to 2035: Demand Accelerates on Cardiovascular Wellness and Sports Nutrition
The global beet supplements market is set to expand through 2035, supported by rising demand for cardiovascular support and clean-label sports nutrition products. Post Views: 2
Nutrition and Function Predict Mortality in Older Atrial Fibrillation Patients
A retrospective cohort study in Guadeloupe found that undernutrition, low functional autonomy, and high comorbidity burden were independently associated with 12-month mortality in older adults with non-valvular atrial fibrillation. Post Views: 2
Potato Protein Market Forecast to 2035, Driven by Plant-Based Nutrition Demand and Clean-Label Trends
The global potato protein market is set to expand through 2035, supported by rising demand for plant-based and clean-label ingredients in food and feed. Post Views: 2
